Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables.

by Jose A Muñoz-Moreno, Núria Pérez-Álvarez, Amalia Muñoz-Murillo, Anna Prats, Maite Garolera, M Àngels Jurado, Carmina R Fumaz, Eugènia Negredo, Maria J Ferrer, Bonaventura Clotet
Published 2014-01-01

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.

by Jose A Muñoz-Moreno, Anna Prats, José Moltó, Maite Garolera, Núria Pérez-Álvarez, Crisanto Díez-Quevedo, Cristina Miranda, Carmina R Fumaz, Maria J Ferrer, Bonaventura Clotet, TRIANT-TE Study Group
Published 2017-01-01

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

by José R Santos, José A Muñoz-Moreno, José Moltó, Anna Prats, Adrià Curran, Pere Domingo, Josep M Llibre, Daniel R McClernon, Isabel Bravo, Jaume Canet, Victoria Watson, David Back, Bonaventura Clotet
Published 2013-01-01

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men

by Carmina R. Fumaz PhD, Aintzane Ayestaran PhD, Nuria Perez-Alvarez PhD, Jose A. Muñoz-Moreno PhD, Maria Jose Ferrer MS, Eugenia Negredo MD, PhD, Bonaventura Clotet MD, PhD
Published 2017-05-01

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

by Anna Prats, Ignacio Martínez-Zalacaín, Beatriz Mothe, Eugènia Negredo, Núria Pérez-Álvarez, Maite Garolera, Sira Domènech-Puigcerver, Pep Coll, Michael Meulbroek, Anna Chamorro, Carmina R. Fumaz, Maria J. Ferrer, Bonaventura Clotet, Carles Soriano-Mas, Jose A. Muñoz-Moreno
Published 2021-05-01